Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
Create a free accountThis page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Armata Pharmaceuticals, Inc.Listing on record | BuyD (derivative) | n/a (Converted to USD in the nightly refresh) | SEC | ||
Entasis Therapeutics Holdings Inc.Listing unverified | Buy | $25.7M | conv 74Unusual size | SEC | |
Entasis Therapeutics Holdings Inc.Listing unverified | Buy | $16.7M | conv 27 | SEC | |
Entasis Therapeutics Holdings Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Entasis Therapeutics Holdings Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Armata Pharmaceuticals, Inc.Listing on record | BuyD (derivative) | $9M | SEC | ||
Armata Pharmaceuticals, Inc.Listing on record | Buy | $18.1M | conv 47Unusual size | SEC | |
Armata Pharmaceuticals, Inc.Listing on record | Buy | $4M | conv 31 | SEC | |
Entasis Therapeutics Holdings Inc.Listing unverified | BuyD (derivative) | $12.5M | SEC | ||
Entasis Therapeutics Holdings Inc.Listing unverified | Buy | $12.5M | conv 63 | SEC | |
Armata Pharmaceuticals, Inc.Listing on record | Buy | $6.1M | conv 27First in 12mo | SEC | |
Armata Pharmaceuticals, Inc.Listing on record | BuyD (derivative) | $6.1M | First in 12mo | SEC |